ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,309.39
0.05%
Brent Oil
83.575
0.02%
Bitcoin
61,500.53
0.53%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eyegate Pharmaceuticals Inc (EYEGW)

  7. Eyegate Pharmaceuticals Inc (EYEGW) News

Eyegate Pharmaceuticals (EYEGW)

Eyegate Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EYEGW
DateTimeSourceHeadlineSymbolCompany
21/09/201613:30GlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
13/09/201613:30GlobeNewswire Inc.EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of DefenseNASDAQ:EYEGWEyegate Pharmaceuticals Inc
12/09/201613:30GlobeNewswire Inc.EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/09/201613:30GlobeNewswire Inc.EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
10/08/201621:50GlobeNewswire Inc.EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
01/08/201613:30GlobeNewswire Inc.EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammat...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
30/06/201618:00GlobeNewswire Inc.EyeGate Announces Completion of $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
27/06/201613:00GlobeNewswire Inc.EyeGate Announces $3.77 Million Registered Direct OfferingNASDAQ:EYEGWEyegate Pharmaceuticals Inc
01/06/201613:30GlobeNewswire Inc.EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation an...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
24/05/201623:00GlobeNewswire Inc.EyeGate Pharma Announces At The Market Issuance ProgramNASDAQ:EYEGWEyegate Pharmaceuticals Inc
13/05/201622:25GlobeNewswire Inc.Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
06/05/201613:30GlobeNewswire Inc.EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and DevelopmentNASDAQ:EYEGWEyegate Pharmaceuticals Inc
28/04/201616:46GlobeNewswire Inc.EyeGate Pharma to Present Four Posters at ARVO 2016 Annual Meeting Supporting Development of CMHA-SNASDAQ:EYEGWEyegate Pharmaceuticals Inc
27/04/201621:05GlobeNewswire Inc.EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial OfficerNASDAQ:EYEGWEyegate Pharmaceuticals Inc
29/03/201621:45GlobeNewswire Inc.EyeGate Reports Full-year 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
10/03/201600:46GlobeNewswire Inc.EyeGate Pharma Acquires Jade TherapeuticsNASDAQ:EYEGWEyegate Pharmaceuticals Inc
10/03/201600:46GlobeNewswire Inc.EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437NASDAQ:EYEGWEyegate Pharmaceuticals Inc
19/01/201613:30GlobeNewswire Inc.EyeGate Pharma Enrolls First Patient in Confirmatory Phase 3 Clinical Trial EGP-437-006 for Non-Infectious Anterior UveitisNASDAQ:EYEGWEyegate Pharmaceuticals Inc
14/01/201614:49GlobeNewswire Inc.Eyegate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 12th Annual Investor ConferenceNASDAQ:EYEGWEyegate Pharmaceuticals Inc
12/11/201513:30GlobeNewswire Inc.EyeGate Reports Third Quarter 2015 Financial Results and Provides Business UpdateNASDAQ:EYEGWEyegate Pharmaceuticals Inc
05/11/201513:45GlobeNewswire Inc.EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial of Iontophoretic EGP-437 Ophthalmic Solution in Macular Edem...NASDAQ:EYEGWEyegate Pharmaceuticals Inc
15/10/201513:30GlobeNewswire Inc.EyeGate Pharma Receives USPTO Notice of Allowance for Next Generation of Proprietary Iontophoretic Delivery SystemNASDAQ:EYEGWEyegate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EYEGW

Your Recent History

LSE
GGP
Greatland Gold
LSE
INSP
Inspirit Energy
LSE
BIRD
Blackbird
LSE
EDEN
Eden Research
LSE
CHAR
Chariot
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved